Complex Regional Pain Syndrome (CRPS) Musculoskeletal Diseases Algoneurodystrophy
Conditions
Interventions
Gabapentin versus placebo
Sponsors
University Hospital Maastricht (The Netherlands) - Pain Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with Complex Regional Pain Syndrome (CRPS) 2. With pain Visual Analogue Scale (VAS) greater than 3 3. Have undergone sympathetic blocks, mannitol infusions and Transcutaneous Electrical Nerve Stimulation (TENS) without success
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
Netherlands
Outcome results
None listed